Your session is about to expire
← Back to Search
Behavioral Intervention
TranS-C for Mild Cognitive Impairment
N/A
Recruiting
Research Sponsored by University of California, Berkeley
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline
Awards & highlights
Study Summary
This trial looks at how different types of memory support help people with mild memory loss.
Who is the study for?
This trial is for English-speaking individuals aged 60 or older who are experiencing memory loss and sleep issues. They must have mild cognitive impairment (MCI) with specific scores on the Montreal Cognitive Assessment, access to a computer and internet, and be able to attend weekly sessions. Those with progressive mental/physical illnesses or night shift work are excluded.Check my eligibility
What is being tested?
The study tests a Transdiagnostic sleep and circadian intervention (TranS-C) aimed at improving memory in patients with mild cognitive impairment compared to those without MCI. It explores which memory support methods are most effective.See study design
What are the potential side effects?
Since TranS-C is a non-pharmaceutical intervention focusing on behavioral strategies, significant side effects are not expected; however, participants may experience changes in their sleep patterns or stress due to new routines.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number and accuracy of applications of the material covered in the prior treatment session in which constructive memory supports were delivered
Number and accuracy of applications of the material covered in the prior treatment session in which non-constructive memory supports were delivered
Number and accuracy of thoughts about the material covered in the prior treatment session in which constructive memory supports were delivered
+3 moreSecondary outcome measures
Acceptability of constructive memory support
Other outcome measures
British Columbia Cognitive Complaints Inventory
Cognitive Failures Questionnaire
Learning behavior exhibited by the patient
+5 moreTrial Design
2Treatment groups
Active Control
Group I: Constructive memory supportActive Control1 Intervention
Participants will watch videos of a sleep expert delivering treatment components from the Transdiagnostic Sleep and Circadian Intervention (TranS-C). After each video, a team member will deliver constructive memory supports.
Group II: Non-constructive memory supportActive Control1 Intervention
Participants will watch videos of a sleep expert delivering treatment components from the Transdiagnostic Sleep and Circadian Intervention (TranS-C). After each video, a team member will deliver non-constructive memory supports.
Find a Location
Who is running the clinical trial?
University of California, BerkeleyLead Sponsor
181 Previous Clinical Trials
721,076 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have worked overnight for more than 2 nights per week in the last 3 months.I can attend weekly sessions on the same day each week.I have an ongoing and worsening mental, physical, or neurological condition.I am unable or unwilling to follow the study's procedures or treatments.You scored between 19 and 25 on a cognitive test for the MCI group, or between 26 and 30 for the non-MCI group.I am 60 years old or older.You are having trouble sleeping and with your body's natural rhythm.
Research Study Groups:
This trial has the following groups:- Group 1: Constructive memory support
- Group 2: Non-constructive memory support
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there currently an opportunity to enrol in this research project?
"According to clinicaltrials.gov, this investigation is not currently enrolling patients as the last edit was made on December 20th 2022. Despite its inactivity, there are 112 other trials actively recruiting from around the world at present."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger